ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,253, issued on April 7, was assigned to MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNGDER WISSENSCHAFTEN E.V. (Munich).
"HIV inhibitors" was invented by Marina V. Rodnina-Wintermeyer (Gottingen, Germany), Natalia Korniy (Gottingen, Germany), Ekaterina Samatova (Gottingen, Germany) and Frank Peske (Hannover, Germany).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a compound comprising of the nucleotide sequence UAA or TAA and a binding site for the covalent attachment of leucine (Leu), wherein said compound is recognized by a ribosome, for use in medicine."
The patent was filed on July 24, 2019, under Application No. 17/262,70...